NASDAQ · Biotechnology

Virax Biolabs Group Limited Ordinary Shares (VRAX)

$0.33 -12.89%
19 Oversold Daily RSI (14) · 18 Nov 2026

Moving averages

SMA 200$3.66-90.93%

Company profile

Virax Biolabs Group Limited, a biotechnology company, sells, distributes and markets diagnostic test kits and medical technology products and PPE for the prevention, detection, diagnosis and risk management of viral diseases in the field of immunology. The company is headquartered in London, the United Kingdom.

SectorHealthcare
IndustryBiotechnology
Market cap$843,440
P/E ratioNone
EPS$-12.64
Beta1.481
Dividend yield0.00%
52-week high$21.75
52-week low$0.50

Similar stocks in Biotechnology

30 days of PRO Unlimited free, no card

RSI alerts for VRAX

An email when VRAX closes below RSI 30 or above 70. Nothing else.

Data last updated 13 November 2026 at 4:25 AM EST